Business Update
Siegfried signs long-term cooperation pact with Celgene, sells drug-manufacturing facility
Published in Biotech Business Week, January 29th, 2007
Celgene is purchasing the assets for approximately a total of CHF 55.5 million (US$44.51 million) in cash, with an initial payment of CHF 15 million (US$12.03 million). The manufacturing facility has the capability to produce multiple drug substances and initially will be used to produce Revlimid to supply global markets.
"This asset acquisition and collaboration further extends our global manufacturing...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- Market Analysis
Despite progress, tools and platforms for biomarker discovery face numerous challenges - Market Analysis
High healthcare costs boost increased focus on biosimilar markets, market study shows - Market Analysis
Reference pricing methods forced branded, generic drugs into same price groups in Germany - Mergers & Acquisitions
Boston Scientific acquires EndoTex Interventional Systems - Mergers & Acquisitions
Tripos signs definitive agreement to sell discovery research business to Provid Pharma - Angiography
Findings in angiography reported from Fukui Cardiovascular Center - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
